BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 11195799)

  • 1. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.
    Karassa FB; Isenberg DA
    N Engl J Med; 2001 Feb; 344(5):382-3. PubMed ID: 11195799
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
    Burchardi C; Schlöndorff D
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil for lupus nephritis.
    McCune WJ
    N Engl J Med; 2005 Nov; 353(21):2282-4. PubMed ID: 16306526
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis.
    Ann Intern Med; 2015 Jan; 162(1):I24. PubMed ID: 25383607
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.
    Elliott JR; Manzi S
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):354-5. PubMed ID: 16932717
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
    Lau KK; Ault BH; Jones DP; Butani L
    J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
    Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
    Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential therapies for proliferative lupus nephritis.
    Gelber AC; Christopher-Stine L; Fine DM
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15195341
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.
    Glicklich D; Acharya A
    Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lupus nephritis--a work in progress.
    Falk RJ
    N Engl J Med; 2000 Oct; 343(16):1182-3. PubMed ID: 11036127
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
    Killen JP
    N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16482673
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
    Karassa FB
    N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16481648
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological therapy of lupus nephritis.
    Fine DM
    JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
    Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
    Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of lupus nephritis].
    Novak S
    Lijec Vjesn; 2014; 136(7-8):215-9. PubMed ID: 25327009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus nephritis: treatment with mycophenolate mofetil.
    Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
    Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mycophenolate mofetil in lupus nephritis treatment].
    Savio V; Alba P; Babini AM
    Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(4):219-23. PubMed ID: 23751789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.